Vir Biotechnology (VIR) Other Working Capital Changes (2020 - 2026)

Vir Biotechnology (VIR) has 7 years of Other Working Capital Changes data on file, last reported at -$2.3 million in Q1 2026.

• For the quarter ending Q1 2026, Other Working Capital Changes fell 26.56% year-over-year to -$2.3 million; the trailing twelve-month figure through Mar 2026 stood at -$7.8 million (up 62.2% YoY), and the FY2025 full-year result was -$7.4 million, up 68.0% from the prior year.
• Other Working Capital Changes advanced to -$2.3 million in Q1 2026, from -$2.3 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $51.0 million in Q2 2024 to a low of -$50.2 million in Q1 2024.
• A 5-year average of -$992058.8 and a median of -$14000.0 in 2023 frame the typical range for Other Working Capital Changes.
• Peak annual rise in Other Working Capital Changes reached 1000.0% in 2022, while the deepest fall reached 9492.31% in 2022.
• Tracing VIR's Other Working Capital Changes over 5 years: stood at $2.2 million in 2022, then slumped by 244.92% to -$3.1 million in 2023, then plunged by 301.63% to -$12.6 million in 2024, then jumped by 81.56% to -$2.3 million in 2025, then rose by 2.15% to -$2.3 million in 2026.
• Business Quant data shows VIR's Other Working Capital Changes at -$2.3 million in Q1 2026, -$2.3 million in Q4 2025, and -$1.8 million in Q3 2025.